NEW YORK (360Dx) – If field trials prove successful, a point-of-care diagnostic test for tuberculosis could be available for less than $2 in resource-limited countries.
The test's developer, Hema Diagnostic Systems, a subsidiary of Generex Biotechnology, further noted that the test can get results in 15 minutes from a single drop of blood.
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
